Boomerang Ventures — 2025 Investments
3 investments dated 2025 · listed companies and verified rows first · show all
SynchNeuro develops a non-invasive, behind-the-ear wearable sensor that analyzes brain signals (EEG) to continuously monitor glucose levels, sleep quality, and other metabolic metrics.
AI & Machine LearningDigital HealthMedical Devices
Casey Halpern(Founder & Chairman)Emily Mirro(Co-Founder & President)Heonsoo Lee(Chief Scientist)
HealthtechSeneca, US
Darren Schaupp(Executive Officer, Director)Eric Beier(Director)
BoardJames Bauler(Director)Stephen Fischbach(Director)Warren Dodge(Director)
Sonara provides a hybrid care model for opioid treatment programs that combines at-home medication management with remote monitoring and clinical oversight.
Digital HealthHealthtechMedical DevicesDallas, US
Michael Giles(Chief Executive Officer)JUSTIN GELLER(Executive Officer)
BoardRACHEL KERN(Director)DANIEL R. KARLIN(Director)
Co-investorsRoyal Street Ventures Management Company, LlcAcumen AmericaFirst Trust Capital PartnersSorenson Impact Foundation
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.